The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksR4E.L Regulatory News (R4E)

  • There is currently no data for R4E

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Completion of Bank Refinancing

4 Dec 2015 11:50

RNS Number : 0602I
Reach4Entertainment Enterprises PLC
04 December 2015
 

04 December 2015

 

reach4entertainment enterprises plc

("r4e", the "Company" or the "Group")

 

Completion of Bank Refinancing with AIB

 

The Board of r4e is pleased to announce that the Company has today completed its Bank Refinancing with AIB announced on 13 November 2015.

 

The Placing

The Company has completed the Placing to raise £4.0 million (before expenses). The Placing involved the placing of 400,000,000 New Ordinary Shares with new and existing shareholders at a price of 1 penny per share. The Placing was arranged by Allenby Capital Limited.

 

New Facility

The Company has entered into the New Facility with PNC Business Credit, a trading style of PNC Financial Services UK Ltd. The New Facility is a three year secured asset based debt facility of £9.5 million being made up of a £1 million term loan and a revolving credit facility of up to £8.5 million based on qualifying accounts receivable.

 

Bank Refinancing

The Company has repaid its existing loan facility agreement of £14,785,000 ("Facility Agreement") with AIB, as follows:

 

- the Company has paid AIB the Cash Settlement, being £9 million plus certain expenses, against the termination of the Facility Agreement and release of the security granted in connection with the Facility Agreement. The Cash Settlement has been funded from the proceeds of the Placing and amounts drawn down under the New Facility; and

 

- the Company has granted 24,994,462 Warrants, representing five per cent. of the Enlarged Share Capital as enlarged by the exercise of the Warrants and the Placing, to AIB Joint Ventures, a subsidiary of AIB. The Warrants are exercisable for five years at an exercise price of 1 penny per Warrant, only when the closing mid-market price of a New Ordinary Share reaches 5 pence or more on any Trading Day during that five year period, subject to the right to exercise earlier upon the occurrence of certain specified Acceleration Events (as defined in the Warrant Instrument).

 

The same definitions apply throughout this announcement as are applied in the Circular, published on 13 November 2015, copies of which are available on the Company's website, www.r4e.com.

 

Enquiries:

 

reach4entertainment enterprises plc

David Stoller, Executive Chairman

 

+44 (0) 20 7968 1655

Allenby Capital (Nominated Adviser and Broker)

Jeremy Porter/James Reeve

 

+44 (0) 20 3328 5656

Novella Communications (Financial PR)

Tim Robertson / Ben Heath

+44 (0) 20 3151 7008

+44 (0) 7900 927650

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAFALELPSFFF
Date   Source Headline
2nd Sep 20206:31 pmRNSHolding(s) in Company
27th Aug 20205:30 pmRNSReach4entertainment Enterprises
25th Aug 202011:04 amRNSHolding(s) in Company
21st Aug 20204:54 pmRNSResult of GM and cancellation from AIM
20th Aug 20207:42 amRNSClaim
18th Aug 20207:00 amRNSDirector shareholding
14th Aug 20207:00 amRNSDirector shareholding
13th Aug 20208:38 amRNSHolding(s) in Company
10th Aug 20205:30 pmRNSHolding(s) in Company
10th Aug 202011:01 amRNSHolding(s) in Company
10th Aug 202011:00 amRNSHolding(s) in Company
7th Aug 20203:03 pmRNSDirector/PDMR Dealing
7th Aug 20209:23 amRNSDirector shareholding - Replacement
7th Aug 20207:00 amRNSDirector shareholding
6th Aug 20205:30 pmRNSHolding(s) in Company
6th Aug 20207:00 amRNSHolding(s) in Company
4th Aug 20207:00 amRNSProposed cancellation of AIM admission
4th Aug 20207:00 amRNSTotal Voting Rights
21st Jul 20204:44 pmRNSResult of GM
3rd Jul 20207:00 amRNSTotal Voting Rights
1st Jul 20209:06 amRNSAIM Rule 17 and Schedule 2(g) update
30th Jun 20202:49 pmRNSResult of AGM
30th Jun 20207:00 amRNSNotice of GM
29th Jun 20207:00 amRNSFinal Results
5th Jun 202010:17 amRNSNotice of AGM
4th Jun 20207:00 amRNSTotal Voting Rights
7th May 20207:00 amRNSCOVID-19 Update
4th May 20207:00 amRNSTotal Voting Rights
3rd Apr 20207:00 amRNSTotal Voting Rights
20th Mar 20207:00 amRNSCovid-19 (Coronavirus) update statement
4th Mar 20207:00 amRNSBlock Listing Six Monthly Return
4th Mar 20207:00 amRNSTotal Voting Rights
18th Feb 20207:00 amRNSYear-end trading update
4th Feb 20207:00 amRNSTotal Voting Rights
3rd Jan 20207:00 amRNSTotal Voting Rights
4th Dec 20197:00 amRNSTotal Voting Rights
4th Nov 20197:00 amRNSTotal Voting Rights
4th Oct 20197:00 amRNSTotal Voting Rights
30th Sep 20197:00 amRNSInterim Results
4th Sep 20197:00 amRNSTotal voting rights
2nd Aug 20197:00 amRNSTotal Voting Rights
30th Jul 201911:55 amRNSCapital Reduction Update
16th Jul 20194:01 pmRNSCapital Reduction Update
11th Jul 20191:43 pmRNSHolding(s) in Company
9th Jul 20194:34 pmRNSHolding(s) in Company
4th Jul 20197:00 amRNSTotal Voting Rights
28th Jun 201911:24 amRNSResult of AGM
7th Jun 20197:00 amRNSCorporate Update re. Dewynters Germany
4th Jun 20197:00 amRNSTotal voting rights
3rd Jun 20197:00 amRNSAnnual Report, AGM and Proposed Capital Reduction

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.